- Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk distance, cardiac effort and quality of life - Case study ...
Cresilon representatives will be available to talk about how TRAUMAGEL can be easily deployed to control bleeding in seconds across emergency response and military environments at the poster session ...
SAN DIEGO, Sept. 25, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor therapies, ...
At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were ...
Two new studies published in Anaesthesia analyzing pain and other factors connected with day surgery in the UK show that ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this 12-part journey ...
The 36-month PFS rate for patients with del (17p) and/or TP53 mutation was 87% and for patients without del (17p) and TP53 mutation was 89%. The safety profile of BRUKINSA plus venetoclax was ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Looking back on 2025, Neda Shamie shares how a challenging monocular patient reinforced the importance of patience, presence, ...
Author describes symptoms of life threatening illness that might be mistaken for a normal part of the aging process in older patients. Falls, weakness, decline in function, dizziness, or altered ...
Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure freedom New X-TOLE OLE data analysis supports the ability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback